ALKHATIB, MOHAMMAD OMAR AHMAD
 Distribuzione geografica
Continente #
NA - Nord America 197
AS - Asia 131
EU - Europa 82
SA - Sud America 32
AF - Africa 2
OC - Oceania 1
Totale 445
Nazione #
US - Stati Uniti d'America 190
SG - Singapore 73
BR - Brasile 28
IT - Italia 28
CN - Cina 27
HK - Hong Kong 14
DE - Germania 13
IE - Irlanda 13
VN - Vietnam 8
CA - Canada 7
FI - Finlandia 5
SE - Svezia 5
GB - Regno Unito 4
IN - India 4
RU - Federazione Russa 4
BD - Bangladesh 2
FR - Francia 2
NL - Olanda 2
PL - Polonia 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
ES - Italia 1
IQ - Iraq 1
KR - Corea 1
UA - Ucraina 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 445
Città #
Singapore 44
Chandler 24
Beijing 14
Hong Kong 14
Wilmington 13
Rome 12
Ashburn 11
Dublin 9
Fairfield 7
Colorado Springs 6
Ho Chi Minh City 6
New York 6
Buffalo 5
Los Angeles 5
Munich 5
Ann Arbor 4
Council Bluffs 4
Medford 4
Santa Clara 4
São Paulo 4
Brooklyn 3
Cagliari 3
Cambridge 3
Chennai 3
Edmonton 3
Seattle 3
Stockholm 3
The Dalles 3
Turku 3
Campo Grande 2
Chicago 2
Creede 2
Dallas 2
Gainesville 2
Guangzhou 2
Hanoi 2
Houston 2
Lappeenranta 2
Lawrence 2
Nuremberg 2
San Jose 2
Toronto 2
Warsaw 2
Woodbridge 2
Abidjan 1
Abre Campo 1
Amsterdam 1
Araçariguama 1
Araçuaí 1
Arezzo 1
Baghdad 1
Barra Bonita 1
Bauru 1
Berlin 1
Bismarck 1
Boston 1
Cajamar 1
Canto do Buriti 1
Caracas 1
Carney 1
Charlotte 1
Colinas 1
Dnipro 1
Dracena 1
Düsseldorf 1
Elk Grove Village 1
Estación Colina 1
Florianópolis 1
Fortaleza 1
Guaranésia 1
Hyderabad 1
Ipatinga 1
Islington 1
Johannesburg 1
Kemerovo 1
Kilburn 1
Las Vegas 1
Leandro N. Alem 1
Leme 1
Livramento do Brumado 1
London 1
Manaus 1
Manchester 1
Montreal 1
Orem 1
Palo Alto 1
Phoenix 1
Prague 1
Praia Grande 1
Redondo Beach 1
Ribeirão das Neves 1
Richardson 1
Roubaix 1
Sabinópolis 1
San Diego 1
San Francisco 1
Santa Cruz do Capibaribe 1
Seoul 1
Shanghai 1
Sydney 1
Totale 314
Nome #
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 134
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation 106
Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach 64
SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays 60
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach 58
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy 40
Impact of viral genetic determinants in modulating viral pathogenicity: focus on SARS-Cov-2 and chronic hepatitis viruses 23
Totale 485
Categoria #
all - tutte 2.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.531


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 8 10 4 2 0 2 0
2021/202241 1 1 0 1 1 11 2 5 10 1 0 8
2022/202368 5 5 4 5 21 14 7 0 1 0 5 1
2023/202422 3 3 1 0 1 5 3 1 4 1 0 0
2024/2025180 4 34 8 5 2 12 46 12 9 10 15 23
2025/2026148 31 12 30 36 30 9 0 0 0 0 0 0
Totale 485